CTNNB1 and hepatocellular carcinoma: At least one mutation in TP53 gene was detected in 50% (15/30) of cfDNA samples versus 33.3% (10/30) of HCC tissue, and CTNNB1 was mutated in 10% of cfDNA (3/30) and 33.3% (10/30) of HCC tissue of patients.